Insider · CIK 0001581954

Higgons John Duncan

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001581954

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-24	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-06-18	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2021-04-15	Jounce Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$10.00	−$2,000	9,713
2021-03-15	Jounce Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$12.80	−$2,560	9,913
2021-02-16	Jounce Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$11.78	−$2,356	10,113
2021-01-21	Jounce Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$11.11	−$2,222	10,313
2021-01-20	Jounce Therapeutics, Inc.S Sale	Director	SSale	−1,500 sh	$12.00	−$18K	10,513
2020-06-26	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2020-06-26	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13.6K sh	—	—	13,550
2020-01-06	Jounce Therapeutics, Inc.S Sale	Director	SSale	−1,500 sh	$8.11	−$12.2K	12,013
2019-06-12	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2018-06-19	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+13.6K sh	—	—	13,550
2017-02-01	Jounce Therapeutics, Inc.P Purchase	Director	PPurchase	+6,700 sh	$16.00	+$107K	27,025
2016-01-04	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+57K sh	$2.34	+$133K	118,859
2016-01-04	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+1,975 sh	$31.64	+$62.5K	120,834
2016-01-04	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−57K sh	—	—	182,088
2016-01-04	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−1,975 sh	—	—	180,113
2015-12-15	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−20K sh	$50.09	−$1M	61,835
2015-12-03	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)A Award	Chief Operating Officer	AAward	+34.1K sh	—	—	239,112
2015-11-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10.9K sh	$0.47	+$5,127.23	92,744
2015-11-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,479 sh	$0.47	+$1,165.13	95,223
2015-11-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,612 sh	$2.34	+$15.5K	101,835
2015-11-16	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−20K sh	$61.51	−$1.23M	81,835
2015-11-16	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10.9K sh	—	—	214,113
2015-11-16	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,479 sh	—	—	211,634
2015-11-16	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,612 sh	—	—	205,022
2015-10-15	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$0.30	+$3,025	91,835
2015-10-15	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+8,843 sh	$0.30	+$2,675.007	100,678
2015-10-15	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+1,157 sh	$0.47	+$543.79	101,835
2015-10-15	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−20K sh	$71.04	−$1.42M	81,835
2015-10-15	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	235,022
2015-10-15	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,843 sh	—	—	226,179
2015-10-15	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−1,157 sh	—	—	225,022
2015-10-07	AGIOAGIOS PHARMACEUTICALS, INC.G Gift	Chief Operating Officer	GGift	−70K sh	—	—	81,835
2015-09-30	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$0.30	+$3,025	151,835
2015-09-30	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	245,022
2015-09-15	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,480 sh	$0.30	+$750.2	144,315
2015-09-15	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+17.5K sh	$0.30	+$5,299.8	161,835
2015-09-15	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−20K sh	$91.11	−$1.82M	141,835
2015-09-15	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,480 sh	—	—	272,542
2015-09-15	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−17.5K sh	—	—	255,022
2015-08-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$0.30	+$3,025	141,835
2015-08-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	275,022
2015-08-17	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+20K sh	$0.30	+$6,050	151,835
2015-08-17	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−20K sh	$92.24	−$1.84M	131,835
2015-08-17	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−20K sh	—	—	285,022
2015-08-06	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$0.30	+$3,025	131,835
2015-08-06	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	305,022
2015-07-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+8,264 sh	$0.30	+$2,499.86	130,099
2015-07-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+11.7K sh	$0.30	+$3,550.14	141,835

Recent filings

Accepted (ET)
Jun 284
Higgons John Duncan0001640455-22-000070
SEC(opens sec.gov)
Jun 224
Higgons John Duncan0001640455-21-000111
SEC(opens sec.gov)
Apr 164
Higgons John Duncan0001640455-21-000074
SEC(opens sec.gov)
Mar 174
Higgons John Duncan0001640455-21-000070
SEC(opens sec.gov)
Feb 184
Higgons John Duncan0001640455-21-000040
SEC(opens sec.gov)
Jan 224
Higgons John Duncan0001640455-21-000017
SEC(opens sec.gov)
Jul 24/A
Higgons John Duncan0001640455-20-000086
SEC(opens sec.gov)
Jun 294
Higgons John Duncan0001640455-20-000070
SEC(opens sec.gov)
Jan 84
Higgons John Duncan0001640455-20-000002
SEC(opens sec.gov)
Jun 134
Higgons John Duncan0001640455-19-000054
SEC(opens sec.gov)
Jun 214
Higgons John Duncan0001640455-18-000084
SEC(opens sec.gov)
Feb 24
Jounce Therapeutics, Inc.0001104659-17-006178
SEC(opens sec.gov)
Jan 54
AGIOS PHARMACEUTICALS INC0001209191-16-089018
SEC(opens sec.gov)
Dec 174
AGIOS PHARMACEUTICALS INC0001209191-15-085756
SEC(opens sec.gov)
Dec 74
AGIOS PHARMACEUTICALS INC0001209191-15-083759
SEC(opens sec.gov)
Nov 184
AGIOS PHARMACEUTICALS INC0001209191-15-080927
SEC(opens sec.gov)

Companies

Address

C/O AGIOS PHARMACEUTICALS, INC. 38 SIDNEY STREET, 2ND FLOOR

CAMBRIDGE, MA, 02139